Ningbo Sanxing Medical Electric Co (601567) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 reached RMB 3.63 billion, up 20.03% year-over-year; net profit attributable to shareholders was RMB 489 million, up 34.33% year-over-year.

• Orders on hand totaled RMB 15.717 billion, up 26.12% year-over-year; overseas power distribution orders surged 134.05% to RMB 1.667 billion.

Financial highlights

• Operating income: RMB 3.63 billion, up 20.03% year-over-year.

• Net profit attributable to shareholders: RMB 489 million, up 34.33% year-over-year.

• Basic and diluted EPS: RMB 0.35, up 34.62% year-over-year.

• Net cash flow from operating activities: -RMB 148 million, down from RMB 99 million last year, mainly due to increased payments for materials.

• Total assets at quarter-end: RMB 24.53 billion; shareholders' equity: RMB 12.59 billion.

Key financial ratios and metrics

• Weighted average ROE: 3.96%, up 0.70 percentage points year-over-year.

• Gross margin improved, with operating costs rising slower than revenue.

• Net margin and EPS both increased significantly year-over-year.